#PrecisionMedicine is barreling to the forefront of healthcare these days . It’s hard to keep up with the endless stream of updates, but Twitter’s a good tool to keep up with the news.
Many of you are already following precision/personalized/individualized medicine pioneers like Eric Topol, or Craig Venter, or Francis Collins.
However, here are some Tweeters that are leading social media’s precision medicine presence:
Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
1. Robert West, a self-described “personalized medicine evangelist and über patient advocate” – as well as “Connector.of.Medical.Dots.” A vetted go-to source for current, relevant information on precision medicine.
Prognostic landscape of genes & immune cells across human cancers @NatureMedicine http://t.co/xBAysjudPB #PM101 #PrecisionMedicine #cancer
— Robert West, PhD ✝️ ⚕️#PM101 🟦 (@westr) July 20, 2015
2. Ethan Perlstein, founder of Perlstein Lab. An “indie scientist,” Perlstein takes a unique spin on orphan drug discovery with the mantra, “leave no mutation left behind.” He’s opinionated, sure, but isn’t that why we look to Twitter?
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Handle: @eperlste
Experimental drugs in search of a disease indication is indecision medicine, not precision medicine.
— Ethan Perlstein (@eperlste) July 20, 2015
3. Muin Khoury, director of the CDC Office of Public Health Genomics. Just a rich source for academic advancement in genomics and precision medicine – particularly as they apply to population health.
Handle: @DrKhouryCDC
How can we use genetic stratification in population screening for cancer? Opportunities & challenges http://t.co/pFKgHsOi5J
— CDC Genomics & Precision Health (@CDC_Genomics) July 18, 2015
4. Geoff Ginsburg, director of the Center for Applied Genomics & Precision Medicine at Duke University. Ginsburg’s a pioneer in translational genomics, and works heavily in biomarker-informed clinical trials. He’s a bit of a White House darling.
Handle: @PersonalizedMed
#PrecisionMedicine for #diabetes. PPAR-gamma binding site SNPs determine response to TZD drugs http://t.co/MHluKokNYq pic.twitter.com/KIQg7u8IPE
— Geoff Ginsburg (@PersonalizedMed) July 10, 2015
5. Mike Thompson, medical director of early phase cancer and patient-centered research at University of Wisconsin School of Medicine. More immuno-oncologist than precision medicine evangelist, but a worthy Tweeter to follow in this era of tailored therapies.
Handle: @mtmdphd
#PrecisionMedicine in Cancer Care: 3 Key Steps to Moving Beyond the Hype by @JackWestMD [2/4/15] http://t.co/iGMWhiHOqG
— Mike Thompson, MD, PhD, FASCO (@mtmdphd) March 5, 2015
6. Gholson Lyon, MD, PhD is on the faculty at Cold Spring Harbor Laboratory in New York. He also heads up Lyon Labs there, which is all about understanding the pathophysiology of severe neuropsychiatric disorders by using technologies such as whole genome sequencing, induced pluripotent stem cells and deep brain stimulation to investigate these conditions.
Handle: @GholsonLyon
🙂 Scientists in the Twitterverse: Cell http://t.co/E2XleKSPSt
— Gholson Lyon (@GholsonLyon) July 16, 2015
7. David R. Bachinsky, PhD is the Chief Scientific Officer with Molecular Creativity, which uses integrated nanotechnology and molecular genetics to improve diagnostics and gene therapies.
Handle: @drbachinsky
https://twitter.com/drbachinsky/status/623195104317186048
— David R. Bachinsky (@drbachinsky) July 20, 2015
8. Dr. Leroy Hood is the president and co-founder of Institute for Systems Biology and a National Medal of Science recipient. Acct managed by @hsiaoching.
Handle: @ISBLeeHood
From my lab RT @ISBUSA: A breakthrough in understanding the genetic “architecture” of #bipolar disorder http://t.co/LhyIRdivaL
— Dr. Leroy Hood (@ISBLeeHood) February 18, 2015
Update: You might have seen that we expanded the list. It’s not meant to be all encompassing but yes, we updated.